Viewing Study NCT00005033


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-02-27 @ 6:32 AM
Study NCT ID: NCT00005033
Status: COMPLETED
Last Update Posted: 2013-06-21
First Post: 2000-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab in Treating Patients With Recurrent Osteosarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module